StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — Shrikant Chouhan, Kotak Securities

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

byShrikant Chouhan, Kotak SecuritiesHorizon: NA (inferred Swing (≤2wk))19 Aug 2026via ET Now

Entry₹5,044.5Inferred
Target₹5,130
Total upside +1.69% (call closed)
Stop loss₹4,980-1.28% risk
Exit₹4,98020 Aug 2026, 10:15 am
Stop-loss hit-1.28%
Follow Shrikant Chouhan for new calls(26% target hit, 107 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 20 Aug 2026
3 supporting2 neutral0 opposing
Supports the BUY call (3)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·19 Aug · today

Torrent Pharma Shares Trade Higher After Q1 Results

NewsGoogle News·17 Aug · 2d ago

(opens in new tab)

Torrent Pharma షేర్లు జోరు: Q1 ఫలితాల తర్వాత ఇన్వెస్టర్ల ఆసక్తి

NewsGoogle News·17 Aug · 2d ago

(opens in new tab)
Neutral / worth noting (2)

Torrent Pharma Share: Q1 முடிவுகள்! வருவாய் ஜோர், லாபம் மிதமோ?

NewsGoogle News·17 Aug · 2d ago

(opens in new tab)

Torrent Pharma assigned ESG rating of 70 by NSE Sustainability

NewsGoogle News·11 Aug · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from Shrikant Chouhan, Kotak Securities

Every call and its outcome